These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 23089473

  • 1. STAT3 & Cytochrome P450 2C9: a novel signaling pathway in liver cancer stem cells.
    Myung SJ, Yoon JH, Yu SJ.
    Biomed Pharmacother; 2012 Dec; 66(8):612-6. PubMed ID: 23089473
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
    Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS.
    Cancer Lett; 2010 Dec 01; 298(1):9-15. PubMed ID: 20573444
    [Abstract] [Full Text] [Related]

  • 3. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
    Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G.
    Cancer Lett; 2010 Jun 28; 292(2):197-207. PubMed ID: 20053498
    [Abstract] [Full Text] [Related]

  • 4. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M, Nakao K, Goto T, Nishimura D, Kawashimo H, Shibata H, Motoyoshi Y, Taura N, Ichikawa T, Hamasaki K, Eguchi K.
    J Hepatol; 2007 Oct 28; 47(4):546-55. PubMed ID: 17602782
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E.
    Cancer Lett; 2007 Dec 18; 258(2):181-8. PubMed ID: 17920763
    [Abstract] [Full Text] [Related]

  • 6. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 7. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G.
    J Cell Physiol; 2012 May 15; 227(5):2184-95. PubMed ID: 21792937
    [Abstract] [Full Text] [Related]

  • 8. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C, Wang L, Wang H, Yang L, Guo H, Wang X.
    J Cell Biochem; 2013 Sep 15; 114(9):2061-70. PubMed ID: 23553622
    [Abstract] [Full Text] [Related]

  • 9. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G.
    J Pharmacol Exp Ther; 2010 Jul 15; 334(1):285-93. PubMed ID: 20378717
    [Abstract] [Full Text] [Related]

  • 10. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):738-44. PubMed ID: 17904524
    [Abstract] [Full Text] [Related]

  • 11. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
    Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL.
    Clin Cancer Res; 2010 Nov 01; 16(21):5189-99. PubMed ID: 20884624
    [Abstract] [Full Text] [Related]

  • 12. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH, Chen XY, Cai KR.
    Ai Zheng; 2009 Jan 01; 28(1):24-8. PubMed ID: 19448411
    [Abstract] [Full Text] [Related]

  • 13. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW.
    Cancer Lett; 2012 Aug 01; 321(1):27-35. PubMed ID: 22465052
    [Abstract] [Full Text] [Related]

  • 14. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1247-1254. PubMed ID: 27091428
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
    Liu Y, Li PK, Li C, Lin J.
    J Biol Chem; 2010 Aug 27; 285(35):27429-27439. PubMed ID: 20562100
    [Abstract] [Full Text] [Related]

  • 16. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J.
    Apoptosis; 2011 May 27; 16(5):502-10. PubMed ID: 21311975
    [Abstract] [Full Text] [Related]

  • 17. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    Tak E, Lee S, Lee J, Rashid MA, Kim YW, Park JH, Park WS, Shokat KM, Ha J, Kim SS.
    J Hepatol; 2011 Feb 27; 54(2):328-39. PubMed ID: 21056497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
    Huang S, Chen M, Ding X, Zhang X, Zou X.
    Int Immunopharmacol; 2013 Nov 27; 17(3):585-92. PubMed ID: 23973653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.